GlassScriptPhysician profile
Chengcheng Tu
NPI 1538666524
$4,225.12
in general payments reported to CMS, 2019-2025
16 companies · $1,303 in 2025
The $1,303 reported for 2025 was more than what 84% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,990 · 2023: $389 · 2024: $543 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,235.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2022 | |
| Stryker Corporation | $678.02 | 2022-2024 | Variax, Augment Injectable, Asnis |
| Advanced Oxygen Therapy INC. | $664.96 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Lifenet Health | $265.73 | 2023-2025 | Theragenesis Wound Matrix |
| Treace Medical Concepts, INC. | $194.76 | 2022-2025 | |
| Orthofix Medical, INC. | $189.33 | 2022-2025 | Physio-Stim |
| Smith+Nephew, INC. | $184.12 | 2023-2025 | Collagenase Santyl, Oasis |
| Paratek Pharmaceuticals, INC. | $164.20 | 2022-2025 | Nuzyra |
| Abbvie INC. | $142.33 | 2022 | |
| Kerecis Limited | $141.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Averitas Pharma INC. | $111.05 | 2023 | Qutenza |
| Convatec INC. | $96.66 | 2024 | |
| Solventum Corporation | $95.75 | 2025 | Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $39.98 | 2025 | |
| Next Science LLC | $33.43 | 2023 | Xperience, Surgx, Blastx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $23.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chengcheng Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.